Global burden and epidemiological trends of paediatric-onset multiple sclerosis: a cross-sectional analysis of the 2021 global burden of disease study
View abstract on PubMed
Summary
This summary is machine-generated.Paediatric-onset Multiple Sclerosis (POMS) shows a low but increasing global disease burden. This study highlights the need for greater focus and new treatments for this rare autoimmune disorder in children and adolescents.
Area Of Science
- Neurology
- Epidemiology
- Autoimmune Diseases
Background
- Paediatric-onset Multiple Sclerosis (POMS) is a rare central nervous system autoimmune disorder affecting children and adolescents.
- Characterized by recurrent neurological impairment, POMS necessitates a comprehensive understanding of its global impact.
Purpose Of The Study
- To delineate the global disease burden and epidemiological characteristics of POMS.
- To analyze trends in POMS incidence, prevalence, and disability over three decades.
- To project the future disease burden of POMS using predictive modeling.
Main Methods
- Utilized data from the 2021 Global Burden of Disease (GBD) Study (1990-2021).
- Assessed global burden using incidence, prevalence, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs).
- Employed Joinpoint Regression for trend analysis and the Nordpred model for future projections.
Main Results
- In 2021, global POMS incidence was 1,899 and prevalence was 5,276.
- Global DALYs were 3,073 and YLDs were 1,489 in 2021.
- Trends from 1990-2021 showed increases in incidence and prevalence rates, while DALY rates decreased.
- Projections indicate a rise in ASIR and ASPR by 2046, with decreasing DALYs and YLDs rates.
Conclusions
- POMS exhibits a relatively low but persistently increasing disease burden.
- There is a critical need for increased research focus and the development of novel therapeutic strategies for POMS.
- Understanding epidemiological trends is crucial for managing and mitigating the impact of POMS in paediatric populations.
Related Concept Videos
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Selection Bias: This occurs when the study population is not...
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

